Tyra Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio2.132.921.231.90
Price/Tangible Book2.132.921.231.90
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-0.32%-0.30%-0.20%-0.17%-2.01%
Return on Assets (ROA)-0.22%-0.20%-0.13%-0.10%-0.70%
Return on Capital Employed (ROCE)-0.30%-0.38%-0.23%-0.09%-0.66%
Leverage & Solvency Ratios
Debt/Equity0.020.030.010.000.01
Liquidity Ratios
Current Ratio23.8113.8045.1384.098.22
Quick Ratio23.5313.3244.0683.578.19
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-0.12%-0.12%-0.17%-0.05%
FCF Yield-0.10%-0.09%-0.16%-0.04%
Buyback Yield-0.34%-0.02%-2.04%-7.94%0.42%